The independent news organization of Duke University
A medical journal—Blood—published a retraction notice Friday for the paper “Gene-expression patterns predict phenotypes of immune-mediated thrombosis.” Potti served as lead author on the paper,...
Implementing solar panels may make most environmentally conscious individuals feel virtuous, but Duke engineer Nico Hotz has higher standards.
The future of physics is being shaped in a concrete tunnel 574 feet beneath the border of France and Switzerland—and Duke is playing an important role.
Five neurosurgeons for 30 million people.
Dean of Pratt Tom Katsouleas has been overseeing Duke’s engineers for the past three years.
A report scrutinizing the budget and conduct of the National Science Foundation may be called into question itself.
Walking down Coal Pile Drive, students were once greeted by a heap of coal that rivaled the height of the nearby Bryan Research Center.
Fresh, local fruits and vegetables will soon be on the menu for the small and furry residents of the Duke Lemur Center.
Medical students, hospital visitors and patients will see the beginnings of a newly constructed medical campus upon their return to Duke this Fall.
Kids have found a new wonderland—not in Disney movies, but in the world of computer programming.
Lost and found isn’t so straightforward anymore. Anxiety and high-pressure environments specifically hinder one’s ability to find a second item in a dual-target visual search.
As a forerunner in medical research, Duke is leading a new initiative to reform and regulate clinical trials.
Strobe effects are no longer just for the dance floor.
Studying with a highly motivated friend may not be as inspiring as many students may think, according to a recent study.
Some types of water can now sustain fires, instead of putting them out.
Some might say the Duke School of Nursing is often one of the most forgotten aspects of the University, but an alumnus’ recent donation is bringing the School’s “unbelievable trajectory” the...
Dr. Victor Tapson of Duke encouraged the FDA to delay approval of generic versions of the bloodthinner Lovenox without disclosing the fact that he received more than $260,000 from the Lovenox...
Researchers at Duke are attempting to draw lessons from the highly publicized missteps of one of their own.
The recently reorganized Duke Cancer Institute has a new leader.
The Duke community was given a chilling reminder of what could happen if governments do not mobilize to stop global warming.